Shared on06 Sep 25Fair value Increased 2.22%
Analysts raised Argan’s price target to $230.33, citing stronger-than-expected Q2 margins, an improving operating environment, and supportive demand outlook. Analyst Commentary Better-than-expected Q2 margins delivered by the company.
Shared on23 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 7.77%
AnalystConsensusTarget has decreased revenue growth from 13.3% to 11.2%.
Shared on26 Mar 25Fair value Decreased 31%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on11 Mar 25Fair value Decreased 30%
AnalystConsensusTarget has decreased future PE multiple from 30.4x to 20.7x and increased shares outstanding growth rate from 0.0% to 0.0%.